{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:44:37Z","timestamp":1785840277505,"version":"3.56.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jto.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jtho.2026.103892","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T09:22:03Z","timestamp":1785835323000},"page":"103892","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lung Cancer Patient Advocacy Progress and New Challenges Since 2006"],"prefix":"10.1016","volume":"21","author":[{"given":"Jean-Louis","family":"Pujol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Upal Basu","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caleb","family":"Egwuenu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtho.2026.103892_bib1","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.annonc.2024.10.006","article-title":"Lung cancer research and treatment: global perspectives and strategic calls to action","volume":"35","author":"Meyer","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtho.2026.103892_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/tc-2025-059780","article-title":"Through the haze: how the tobacco control community in New Zealand influenced policy change","author":"Shirley","year":"2026","journal-title":"Tob Control"},{"key":"10.1016\/j.jtho.2026.103892_bib4","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.soc.2025.04.005","article-title":"Patient\u2019s participation in lung cancer surgical treatment: the role of patient-reported outcomes and advocacy","volume":"34","author":"Brascia","year":"2025","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.jtho.2026.103892_bib5","doi-asserted-by":"crossref","first-page":"316","DOI":"10.4997\/JRCPE.2014.415","article-title":"Influencing policy--public health advocacy and health inequalities","volume":"44","author":"Smith","year":"2014","journal-title":"J R Coll Physicians Edinb"},{"key":"10.1016\/j.jtho.2026.103892_bib6","series-title":"All rights reserved. Download at WHO Framework Convention on Tobacco Control on January 8, 2026","year":"2003"},{"key":"10.1016\/j.jtho.2026.103892_bib7","doi-asserted-by":"crossref","first-page":"e745","DOI":"10.1016\/S2468-2667(24)00185-3","article-title":"Estimated impact of a tobacco-elimination strategy on lung-cancer mortality in 185 countries: a population-based birth-cohort simulation study","volume":"9","author":"Rey Brandariz","year":"2024","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.jtho.2026.103892_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2025.11.014","article-title":"Population impact of risk-based lung cancer screening on late-stage incidence in Greater Manchester","volume":"21","author":"Goodley","year":"2026","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.103892_bib9","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.chest.2025.05.004","article-title":"The impact of health care disparities on lung cancer screening and treatment","volume":"168","author":"Bade","year":"2025","journal-title":"Chest"},{"key":"10.1016\/j.jtho.2026.103892_bib10","article-title":"Solving access to lung cancer care across Europe","volume":"38","author":"Brooks","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.jtho.2026.103892_bib12","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/JTO.0000000000000433","article-title":"Perception of lung cancer among the general population and comparison with other cancers","volume":"10","author":"Mazi\u00e8res","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.103892_bib13","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jtho.2018.06.006","article-title":"Introduction to the special section: the experience and impact of lung cancer stigma","volume":"13","author":"Hamann","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.103892_bib14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.soncn.2014.11.009","article-title":"Cancer survivorship advocacy","volume":"31","author":"Haylock","year":"2015","journal-title":"Semin Oncol Nurs"},{"key":"10.1016\/j.jtho.2026.103892_bib17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/gm515","article-title":"Lung cancer patient advocacy and participatory medicine","volume":"6","author":"Norris","year":"2014","journal-title":"Genome Med"},{"key":"10.1016\/j.jtho.2026.103892_bib18","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1158\/0008-5472.CAN-12-4553-T","article-title":"Cancer research advocacy: past, present, and future","volume":"73","author":"Perlmutter","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtho.2026.103892_bib19","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/hex.12638","article-title":"Health democracy in Europe: cancer patient organization participation in health policy","volume":"21","author":"Souliotis","year":"2018","journal-title":"Health Expect"},{"key":"10.1016\/j.jtho.2026.103892_bib20","unstructured":"International Association for the Study of Lung Cancer. IASLC Language Guide. IASLC language guide. https:\/\/www.iaslc.org\/IASLCLanguageGuide. Accessed February 8, 2026."},{"key":"10.1016\/j.jtho.2026.103892_bib21","article-title":"Patient advocates and researchers as partners in cancer research: a winning combination","volume":"43","author":"Porter","year":"2023","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.jtho.2026.103892_bib22","article-title":"Access to diagnostics and treatment for people with metastatic EGFR-positive NSCLC: lessons from project PRIORITY","volume":"6","author":"Feldman","year":"2024","journal-title":"JTO Clin Res Rep"},{"key":"10.1016\/j.jtho.2026.103892_bib23","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.jtho.2025.07.117","article-title":"Enhanced versus standard dermatologic management with Amivantamab-Lazertinib in EGFR-mutated advanced NSCLC: the COCOON global randomized controlled trial","volume":"20","author":"Cho","year":"2025","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.103892_bib24","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jtho.2025.09.090","article-title":"OA17.03 the patient voice on required research biopsies: results of a survey study exploring the perspective of patients with lung cancer","volume":"20","author":"Abodunrin","year":"2025","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.103892_bib25","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s11136-014-0893-3","article-title":"Conceptual and practical foundations of patient engagement in research at the Patient-Centered Outcomes Research Institute","volume":"24","author":"Frank","year":"2015","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jtho.2026.103892_bib26","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1093\/jnci\/djaf108","article-title":"Landscape assessment of patient-reported outcome item coverage of tyrosine kinase inhibitor-associated adverse events","volume":"117","author":"Paton","year":"2025","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jtho.2026.103892_bib27","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1159\/000513233","article-title":"Incidence of adverse cutaneous reactions to epidermal growth factor receptor inhibitors in patients with non-small-cell lung cancer","volume":"237","author":"Gisondi","year":"2021","journal-title":"Dermatology"},{"key":"10.1016\/j.jtho.2026.103892_bib28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1200\/JGO.2015.000398","article-title":"International framework for cancer patient advocacy: empowering organizations and patients to create a national call to action on cancer","volume":"1","author":"Schear","year":"2015","journal-title":"J Glob Oncol"},{"key":"10.1016\/j.jtho.2026.103892_bib29","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41591-022-01738-x","article-title":"Priorities for cancer research in low- and middle-income countries: a global perspective","volume":"28","author":"Pramesh","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.jtho.2026.103892_bib30","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.jtho.2020.09.014","article-title":"A call to arms: reducing disparities in lung cancer care worldwide","volume":"15","author":"Adjei","year":"2020","journal-title":"J Thorac Oncol"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155608642600345X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155608642600345X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T09:54:04Z","timestamp":1785837244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155608642600345X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S155608642600345X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtho.2026.103892","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lung Cancer Patient Advocacy Progress and New Challenges Since 2006","name":"articletitle","label":"Article Title"},{"value":"Journal of Thoracic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtho.2026.103892","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103892"}}